Verition Fund Management’s Tenax Therapeutics TENX Stock Holding History

Verition Fund Management’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.7K	Hold	13,589	–	–	﹤0.01%	2000
2026 Q2	$198K	Hold	13,589	–	–	﹤0.01%	1847
2026 Q1	$217K	Buy	+13,589	New	+$184K	﹤0.01%	1927
2023 Q2	–	Sell	-545	Closed	-$20.3K	–	2541
2023 Q1	$20.3K	Buy	+545	New	+$56.8K	﹤0.01%	2008
2018 Q1	–	Sell	-1	Closed	-$16K	–	1312
2017 Q4	$16K	Hold	1	–	–	﹤0.01%	844
2017 Q3	$12K	Hold	1	–	–	﹤0.01%	1128
2017 Q2	$24K	Hold	1	–	–	﹤0.01%	884
2017 Q1	$18K	Hold	1	–	–	﹤0.01%	1132
2016 Q4	$63K	Hold	1	–	–	0.01%	1121
2016 Q3	$74K	Hold	1	–	–	0.01%	1090
2016 Q2	$82K	Hold	1	–	–	0.01%	843
2016 Q1	$66K	Hold	1	–	–	0.01%	677
2015 Q4	$105K	Hold	1	–	–	0.02%	405
2015 Q3	$78K	Hold	1	–	–	0.02%	484
2015 Q2	$145K	Hold	1	–	–	0.03%	522
2015 Q1	$151K	Hold	1	–	–	0.02%	333
2014 Q4	$177K	Sell	1 -1	-50%	-$121K	0.04%	255
2014 Q3	$197K	Hold	2	–	–	0.03%	572
2014 Q2	$306K	Hold	2	–	–	0.03%	405
2014 Q1	$278K	Buy	+2	New	+$396K	0.04%	295

Other funds holding TENX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Verition Fund Management's TENX Position: Q3 2026 in Review

Verition Fund Management held its Tenax Therapeutics (TENX) position steady in Q3 2026 at 13,589 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

Verition Fund Management first reported a position in TENX in Q1 2014 and has held it in 20 quarters since. The position peaked at $306K in Q2 2014. 68 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

Verition Fund Management held 13,589 shares of Tenax Therapeutics worth $25.7K as of Q3 2026.
Verition Fund Management left its Tenax Therapeutics share count unchanged in Q3 2026.
Tenax Therapeutics made up ﹤0.01% of Verition Fund Management's portfolio in Q3 2026, its #2000 holding.
Verition Fund Management first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 20 quarters since.
Verition Fund Management's Tenax Therapeutics position peaked at $306K in Q2 2014.
68 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.